RocGene (Beijing) Technology Co., Ltd.
Home · News ·
New product release 丨 Cardiovascular disease individualized drug gene polymorphism detection solution
Mar 22,2023

Faster | More Convenient

Genetic Testing Solution for Cardiovascular Medication Guidance


One-Stop Solution for Personalized Cardiovascular Medication Genetic Testing


With improved living standards and changing demographics, cardiovascular diseases such as hypertension and hyperlipidemia have become a major threat to public health. According to the 2020 Report on Cardiovascular Health and Diseases in China, cardiovascular diseases are the leading cause of death in China, with an estimated 330 million patients. Elderly patients often require long-term medication, yet the same drug at the same dose can lead to drastically different responses: poor efficacy, ineffectiveness, or increased side effects.


In 2015, the National Health Commission issued the Guidelines for Genetic Testing of Drug Metabolic Enzymes and Drug Targets (for Trial Implementation), recommending that clinicians test polymorphisms including ADRB1 (G1165C), SLCO1B1 (521T>C), ALDH2*2, and CYP2C19*2/*3/*17 before prescribing relevant drugs to improve safety and effectiveness.



Solution Value



Solution Components


High-Throughput Platform

Archimed X Series Real-Time Quantitative PCR System



Rapid Testing Platform

Archimed Mini 16 Series Real-Time Quantitative PCR System



Test Kit

Genetic Polymorphism Detection Kit for Personalized Cardiovascular Medication





One-Click Customized Software

Archimed Analyzer Data Analysis Software

Preloaded amplification programs and analysis parameters. One-click run, analysis, and reporting.


About Rocgene


Founded in 2016, Rocgene (Beijing) Technology Co., Ltd. is a high-tech biotechnology company established by scientists and industry professionals, driven by core technologies. Rocgene transforms cutting-edge life science research into clinically applicable products, developing proprietary research and molecular diagnostic tools.


Rocgene is certified as a National High-Tech Enterprise and Zhongguancun High-Tech Enterprise. It holds 26 patents (12 invention, 9 utility model, 5 design) and 32 software copyrights. It operates a clean workshop of over 10,000 ㎡ in Xuzhou High-Tech Zone. With courage to transcend and ambition to excel, Rocgene aims to be a forward-looking industry leader.



Rocgene Product Series


Latest News
Recommended Products
Continue to Company Website
Copyright © Rocgene (Beijing) Scientific Instruments Co., Ltd. - All Rights Powered by Bomin